A Phase 1, Open-label, Single-dose Study to Evaluate the Effect of Moderate or Severe Renal Impairment on the Pharmacokinetics of Inavolisib
-
Kidney Disorder -
Renal Failure -
Healthy Volunteers
For the latest version of this information please go to www.forpatients.roche.com